Skip to contentC
Collegium Pharmaceutical, Inc
C
COLLCollegium Pharmaceutical, Inc Q1 2017 · 10-Q
Revenue$2.17M$2.17Mno prior Q1 2016 on file Net Income-$23.08M-$23.08MN/M vs Q1 2016 EPS Diluted-$0.79-$0.79N/M vs Q1 2016 Operating Income-$23,176,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Collegium Pharmaceutical, Inc · CIK 1267565 · Engraved from SEC EDGAR
Free Cash Flowderived-$23,717,000— Margins · derivedOperating margin-1067.0%
Net margin-1062.5%
ended Mar 31, 2017 · filed May 10, 2017 · 40 d after period end